At Norstella, our mission is simple: to help our clients bring life-saving therapies to market quicker — and help patients in need. Founded in 2022, but with history going back to 1939, Norstella unites best-in-class brands to help clients navigate the complexities at each step of the drug development life cycle — and get the right treatments to the right patients at the right time.
Each organisation (Citeline, Evaluate, MMIT, Panalgo, The Dedham Group) delivers must-have answers for critical strategic and commercial decision-making. Together, via our market-leading brands, we help our clients:
- Citeline – accelerate the drug development cycle
- Evaluate – bring the right drugs to market
- MMIT – identify barriers to patient access
- Panalgo – turn data into insight faster
- The Dedham Group – think strategically for specialty